NG-094

Hyperthemia (>50 °C) induced heating damage of nearby normal organs and inflammatory diseases are the main challenges for photothermal therapy (PTT) of cancers. To overcome this limitation, a redox‐responsive biomodal tumor‐targeted nanoplatform is synthesized, which can achieve multispectral optoacoustic tomography/X‐ray computed tomography imaging‐guided low‐temperature photothermal‐radio combined therapy (PTT RT). In this study, Bi2Se3 hollow nanocubes (HNCs) are first fabricated based on a mild cation exchange way and Kirkendall effect and then modified with hyaluronic acid (HA) through redox‐cleavable linkage (‐s‐s‐), thus enabling the HNC to target cancer cells overexpressing CD‐44 and control the cargo release profile. Finally, gambogic acid (GA), a type of heat‐shock protein (HSP) inhibitor, which is vital to cells resisting heating‐caused damage is loaded, into Bi2Se3 HNC. Such HNC‐s‐s‐HA/GA under a mild NIR laser irradiation can induce efficient cancer cell apoptosis, achieving PTT under relatively low temperature (≈43 °C) with remarkable cancer cell damage efficiency. Furthermore, enhanced radiotherapy (RT) can also be experienced without depth limitation based on RT sensitizer Bi2Se3 HNC. This research designs a facile way to synthesize Bi2Se3 HNC‐s‐s‐HA/GA possessing theranostic functionality and cancer cells‐specific GSH, but also shows a low‐temperature PTT RT method to cure tumors in a minimally invasive and highly efficient way.

Multifunctional nanomaterials for dual-mode imaging guided cancer therapy are highly desirable in clinical applications. Herein, a flowerlike NiS₂-coated NaLuF₄:Nd (Lu:Nd@NiS₂) nanoparticle was synthesized as a novel therapeutic agent for short-wave infrared light imaging and magnetic resonance imaging to guide photothermal therapy (PTT). The material was then loaded with phenolic epigallocatechin 3-gallate (EGCG), which is a natural heat-shock protein 90 (HSP90) inhibitor. Upon near infrared irradiation, EGCG was released from the Lu:Nd@NiS₂-EGCG, which bound HSP90 and reduced cell tolerance to heat, resulting in a better therapeutic effect at the same elevated temperature. Therefore, with minimal side effects and remarkable antitumor efficacy in vivo, Lu:Nd@NiS₂-EGCG appeared to be a promising photothermal agent for enhanced PTT.